CTRV - Hepion Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/20176/30/20176/30/2016
Net Income-9,449.295-13,079.758-14,891.05-16,998.638
Operating Activities, Cash Flows Provided By or Used In
Depreciation18.78725.82327.99321.525
Adjustments To Net Income-5,245.038-4,423.076-2,468.434-2,904.98
Changes In Accounts Receivables----
Changes In Liabilities-897.695-390.484-2,128.2633,135.022
Changes In Inventories----
Changes In Other Operating Activities-72.786193.992287.644191.973
Total Cash Flow From Operating Activities-15,646.027-17,673.503-19,172.11-16,555.098
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditure--2.425-14.709-6.603
Investments----
Other Cash flows from Investing Activities----
Total Cash Flows From Investing Activities0.9-2.425-14.709-502.206
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings1,331.0581,331.058-10.41-10.41
Other Cash Flows from Financing Activities-1,000-1,754.588-1,754.588-1,754.588
Total Cash Flows From Financing Activities12,523.53913,078.22424,765.62719,898.079
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents-3,121.588-4,597.7045,578.8082,840.775